AU715178B2 - Nucleotide sequence from goat liver - Google Patents

Nucleotide sequence from goat liver Download PDF

Info

Publication number
AU715178B2
AU715178B2 AU16024/97A AU1602497A AU715178B2 AU 715178 B2 AU715178 B2 AU 715178B2 AU 16024/97 A AU16024/97 A AU 16024/97A AU 1602497 A AU1602497 A AU 1602497A AU 715178 B2 AU715178 B2 AU 715178B2
Authority
AU
Australia
Prior art keywords
ala
sequence
val
ile
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU16024/97A
Other languages
English (en)
Other versions
AU1602497A (en
Inventor
Alberto Bartorelli
Bruno Berra
Irma Colombo
Severino Ronchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis SpA filed Critical Zetesis SpA
Publication of AU1602497A publication Critical patent/AU1602497A/en
Application granted granted Critical
Publication of AU715178B2 publication Critical patent/AU715178B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Basic Packing Technique (AREA)
AU16024/97A 1996-02-13 1997-02-11 Nucleotide sequence from goat liver Ceased AU715178B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT96MI000264A IT1282608B1 (it) 1996-02-13 1996-02-13 Sequenza oligonocleotidica da fegato di capra
ITMI96A000264 1996-02-13
PCT/EP1997/000611 WO1997030154A1 (en) 1996-02-13 1997-02-11 Nucleotide sequence from goat liver

Publications (2)

Publication Number Publication Date
AU1602497A AU1602497A (en) 1997-09-02
AU715178B2 true AU715178B2 (en) 2000-01-20

Family

ID=11373242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16024/97A Ceased AU715178B2 (en) 1996-02-13 1997-02-11 Nucleotide sequence from goat liver

Country Status (10)

Country Link
US (1) US6107474A (enExample)
JP (1) JP2000504578A (enExample)
KR (1) KR19990082506A (enExample)
AU (1) AU715178B2 (enExample)
CA (1) CA2246223A1 (enExample)
GB (1) GB2325466B (enExample)
IL (1) IL125737A0 (enExample)
IT (1) IT1282608B1 (enExample)
LT (1) LT4481B (enExample)
WO (1) WO1997030154A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy
WO1996002567A1 (en) * 1994-07-14 1996-02-01 Zetesis S.P.A. Proteins from mammalian liver and their use in oncology

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy
WO1996002567A1 (en) * 1994-07-14 1996-02-01 Zetesis S.P.A. Proteins from mammalian liver and their use in oncology

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MEDLINE ABSTRACT NO. 96409267 *

Also Published As

Publication number Publication date
WO1997030154A1 (en) 1997-08-21
GB2325466B (en) 2000-03-22
HK1016217A1 (en) 1999-10-29
LT98116A (en) 1999-01-25
ITMI960264A0 (enExample) 1996-02-13
CA2246223A1 (en) 1997-08-21
US6107474A (en) 2000-08-22
AU1602497A (en) 1997-09-02
JP2000504578A (ja) 2000-04-18
ITMI960264A1 (it) 1997-08-13
LT4481B (lt) 1999-03-25
IT1282608B1 (it) 1998-03-31
GB2325466A (en) 1998-11-25
IL125737A0 (en) 1999-04-11
GB9817574D0 (en) 1998-10-07
KR19990082506A (ko) 1999-11-25

Similar Documents

Publication Publication Date Title
Beckerandre et al. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences
Xu et al. Presence of a vertebrate fibrinogen-like sequence in an echinoderm.
Chu et al. Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III) collagen. Partial characterization of the 3'end region of the gene.
CA2296841C (en) Tropoelastin derivatives
EP0289287A2 (en) Amyloid peptides
CA2302644A1 (en) Extended cdnas for secreted proteins
CA2296667A1 (en) 5' ests for secreted proteins expressed in brain
WO1995008573A1 (en) Peptide having antithrombotic activity and process for producing the same
CA2297157A1 (en) 5' ests for secreted proteins expressed in testis and other tissues
AU710373B2 (en) Modified low-density lipoprotein receptor
JPS59156284A (ja) ヒト−レラキシンｈ２遺伝子
Ninomiya et al. Structure of the carboxyl propeptide of chicken type II procollagen determined by DNA and protein sequence analysis
Klima et al. Characterization of full-length cDNAs and the gene coding for the human GM2 activator protein
US5302701A (en) Polypeptide having human fibronectin-like cell adhesive activity
JP3181660B2 (ja) ビリルビンオキシダーゼの製造法
JPH07138295A (ja) 新規なヒトタンパク質およびそれをコードする遺伝子
Trapani et al. Genomic organization of the mouse pore-forming protein (perforin) gene and localization to chromosome 10. Similarities to and differences from C9.
Malthiery et al. Sequence of the 5′‐end quarter of the human‐thyroglobulin messenger ribonucleic acid and of its deduced amino‐acid sequence
CA2246223A1 (en) Nucleotide sequence from goat liver
Lutz et al. Structure of cDNA clones and genomic DNA FMRFamide-related peptides (FaRPs) in Helix
US6369198B1 (en) Allelic variant of human STAT3
HU197939B (en) Process for producing deoxyribonucleic acid, or its precursor, determining human growth hormone releasing factor
US20020086848A1 (en) Fanconi-gene II
Graf et al. Mitochondrial import of rat pre-ornithine transcarbamylase: accurate processing of the precursor form is not required for uptake into mitochondria, nor assembly into catalyticaUy active enzyme
AU723543B2 (en) Fanconi-gene II

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
GD Licence registered
TH Corrigenda

Free format text: IN VOL 14, NO 32, PAGE(S) 5877 UNDER THE HEADING LICENCES REGISTERED THE NUMBER OF THE PATENTS SHOULD READ 715178 AND 719203 IN THE NAME OF ZETESIS S.P.A.